NovoCare Pharmacy is Novo Nordisk’s direct-to-patient pharmacy program for Wegovy (semaglutide 2.4 mg), launched to help patients whose insurance does not cover the drug access all dose strengths at a flat monthly cash price. Enrollment requires a valid prescription from a US-licensed clinician and meeting Wegovy’s FDA-approved indications.
Why NovoCare Pharmacy Exists
Insurance coverage for GLP-1 medications used for obesity has been uneven in the United States. Medicare Part D has historically excluded anti-obesity drugs by statute, some commercial plans exclude them, and state Medicaid coverage varies. At the same time, high list prices made out-of-pocket purchase unrealistic for most patients. Novo Nordisk launched NovoCare Pharmacy as a direct-to-patient pathway, selling Wegovy at a discounted flat cash price and shipping it to patients through contracted mail-order pharmacies.
How NovoCare Pharmacy Works
- Your clinician writes a prescription for Wegovy.
- You enroll at NovoCare.com or through your clinician’s office.
- The prescription is routed to a NovoCare-contracted pharmacy.
- You pay the flat monthly cash price by credit card.
- The medication ships to your home in cold-chain packaging.
- You inject once weekly per your clinician’s dose-titration schedule.
Who Qualifies
Eligibility generally requires:
- A valid Wegovy prescription from a US-licensed clinician
- Meeting Wegovy’s FDA-approved indications:
- Adults with BMI ≥ 30 (obesity), or
- Adults with BMI ≥ 27 with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, sleep apnea, cardiovascular disease), or
- Adults with established cardiovascular disease and BMI ≥ 27, per Wegovy’s 2024 CV indication
- Being a US resident with a valid shipping address
- Not using Wegovy through commercial insurance (the program is for self-pay)
Specific eligibility rules and exclusions change; always verify on NovoCare.com.
Pricing Overview
| Path | Typical Cost Pattern | Best For |
|---|---|---|
| Commercial insurance + Wegovy savings card | $0 to $25 per month if covered | Patients with good Wegovy coverage |
| NovoCare Pharmacy direct-to-patient | Flat monthly cash price (see NovoCare.com) | Uninsured or plan excludes Wegovy |
| Retail cash price without program | Often far above NovoCare price | Not recommended if NovoCare is an option |
| Compounded semaglutide (shortage-driven) | Variable; quality and regulatory status differ | No longer broadly available since shortage resolved |
Because list prices and program pricing change, always confirm current numbers before making enrollment decisions.
How Wegovy Itself Works
Wegovy is semaglutide, a once-weekly injectable GLP-1 receptor agonist. It works by mimicking the gut hormone glucagon-like peptide-1, which slows gastric emptying, increases satiety signaling in the brain, and reduces food intake. Clinical trials (the STEP program) showed average weight loss of 14 to 15 percent of body weight over 68 weeks compared with about 2 to 3 percent with lifestyle alone. The SELECT trial later demonstrated a 20 percent reduction in major adverse cardiovascular events in overweight and obese adults with established cardiovascular disease.
For broader context on GLP-1 therapy in diabetes, see our treatment hub.
Dose Titration
| Week | Dose |
|---|---|
| 1 to 4 | 0.25 mg weekly |
| 5 to 8 | 0.5 mg weekly |
| 9 to 12 | 1.0 mg weekly |
| 13 to 16 | 1.7 mg weekly |
| 17+ | 2.4 mg weekly (maintenance) |
Slow titration reduces the nausea, constipation, and bloating that make many people stop GLP-1 therapy early.
Common Side Effects
- Nausea (most common; usually improves after each dose step)
- Constipation or diarrhea
- Vomiting, indigestion, gas
- Injection-site reactions
- Fatigue
- Rare but serious: pancreatitis, gallbladder disease, medullary thyroid cancer risk (contraindicated in patients with personal or family history of MTC or MEN 2)
Always discuss side effects and dose changes with your prescriber; do not self-adjust.
Shipping and Storage
Wegovy ships in an insulated cooler with cold packs. On receipt:
- Refrigerate at 36°F to 46°F (2°C to 8°C) until use.
- After first use, a pen can be kept at room temperature (59°F to 86°F) for up to 28 days or refrigerated.
- Do not freeze. Discard any pen that has been frozen.
- Protect from direct heat and sunlight.
When to Consider NovoCare vs Insurance
- Your plan covers Wegovy → commercial insurance + savings card is almost always cheapest.
- Your plan excludes obesity drugs → NovoCare Pharmacy is typically the best legitimate option.
- You are on Medicare → obesity use is not covered under Part D; cardiovascular indication may be covered for eligible patients. Discuss with prescriber.
- You are uninsured → NovoCare Pharmacy is designed for this situation.
Caveats and Cautions
- Do not buy semaglutide from unverified online sources or gray-market suppliers. Content varies, sterility is unknown, and counterfeit products are documented.
- Compounded semaglutide was widely available during the FDA shortage period; now that the shortage has resolved, compounded versions are more restricted. Ask your clinician about the current regulatory status.
- NovoCare Pharmacy does not substitute for ongoing medical oversight. Continue regular clinician visits for weight, A1C, blood pressure, and side-effect monitoring.
For related reading on semaglutide broadly and how prediabetes can be reversed, GLP-1 therapy is only one tool among several.
The Bottom Line
NovoCare Pharmacy is Novo Nordisk’s direct-to-patient channel for Wegovy, built for people whose insurance will not cover the drug. It offers a flat monthly cash price across all dose strengths with home delivery. If you have commercial insurance coverage, the Wegovy savings card is usually cheaper; if you are uninsured or your plan excludes obesity medications, NovoCare Pharmacy is worth evaluating. Always verify current pricing and eligibility on NovoCare.com before enrolling.
